These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6359519)

  • 1. Immunoreactive hormones in human breast tissues.
    Spring-Mills E; Stearns SB; Smith PH; Numann PJ; Ginsberg SJ
    Surgery; 1983 Dec; 94(6):946-50. PubMed ID: 6359519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly specific sites of prolactin binding in benign and malignant breast tissue.
    Agarwal PK; Tandon S; Agrawal AK; Kumar S
    Indian J Exp Biol; 1989 Dec; 27(12):1035-8. PubMed ID: 2633963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical detection of prolactin binding sites in fine needle aspiration smears of breast lesions.
    Tandon S; Agarwal PK; Mishra KL; Goel A; Kumar S
    Indian J Med Res; 1993 Apr; 98():61-4. PubMed ID: 8344732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin expression and secretion by human breast glandular and adipose tissue explants.
    Zinger M; McFarland M; Ben-Jonathan N
    J Clin Endocrinol Metab; 2003 Feb; 88(2):689-96. PubMed ID: 12574200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of P53 protein and local hGH, IGF-I, IGFBP-3, IGFBP-2 and PRL secretion by human breast cancer explants.
    Milewicz T; Ryś J; Wójtowicz A; Stochmal E; Jach R; Krzysiek J; Gregoraszczuk E; Huras H; Dziadek O
    Neuro Endocrinol Lett; 2011; 32(3):328-33. PubMed ID: 21670726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
    Rose DP; Berke B; Cohen LA
    Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical demonstration of immunoreactive insulin in human breast cancer.
    Castro A; Ziegels-Weissman J; Buschbaum P; Voigt W; Morales A; Nadji M
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):171-82. PubMed ID: 6996061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and de novo biosynthesis of follicle stimulating hormone (FSH) in benign and malignant conditions of human breast.
    Garde SV; Sheth AR; Joseph R; Panchal CJ; Chinoy RF; Sheth NA
    Cancer Lett; 1993 Nov; 75(1):1-9. PubMed ID: 8287377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of prolactin receptors (PRL-R) by lactogenic and steroid hormones in human breast cancer cells in long-term tissue culture (T-47D).
    Leroy-Martin B; Peyrat JP
    Anticancer Res; 1989; 9(3):631-6. PubMed ID: 2764510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone binding by human mammary carcinoma.
    Holdaway IM; Friesen HG
    Cancer Res; 1977 Jul; 37(7 Pt 1):1946-52. PubMed ID: 193630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactogenic hormones stimulate the liver to secrete a factor that acts synergistically with prolactin to promote growth of the pigeon crop-sac mucosal epithelium in vivo.
    Nicoll CS; Hebert NJ; Russell SM
    Endocrinology; 1985 Apr; 116(4):1449-53. PubMed ID: 3882409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated growth hormone levels in sera from breast cancer patients.
    Emerman JT; Leahy M; Gout PW; Bruchovsky N
    Horm Metab Res; 1985 Aug; 17(8):421-4. PubMed ID: 4054832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
    Jaquet P; Hassoun J; Delori P; Gunz G; Grisoli F; Weintraub BD
    J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones.
    Rose DP; Cohen LA; Berke B; Boyar AP
    J Natl Cancer Inst; 1987 Apr; 78(4):627-31. PubMed ID: 3470539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estradiol-dependent collagenolytic enzyme activity in long-term organ culture of human breast cancer.
    Heuson JC; Pasteels JL; Legros N; Heuson-Stiennon J; Leclercq G
    Cancer Res; 1975 Aug; 35(8):2039-48. PubMed ID: 167944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma of the breast associated with hypercalcemia and the presence of parathyroid hormone-like substances in the tumor.
    Hirshorn JE; Vrhovsek E; Posen S
    J Clin Endocrinol Metab; 1979 Feb; 48(2):217-21. PubMed ID: 429476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast disease.
    Candlish W; Kerr IB; Simpson HW
    J Pathol; 1986 Nov; 150(3):163-7. PubMed ID: 3027290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin synthesis and secretion by human breast cancer cells.
    Ginsburg E; Vonderhaar BK
    Cancer Res; 1995 Jun; 55(12):2591-5. PubMed ID: 7780973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.